Yin Yongmei, Kuai Shougang, Liu Jun, Zhang YingYing, Shan Zhongbao, Gu Lan, Huang Qiusheng, Pei Hao, Wang Jun
Radiology Department, The Fifth People's Hospital of Wuxi, Jiangnan University, Wuxi, Jiangsu, China.
Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi, Jiangnan University, Wuxi, Jiangsu, China.
Arch Med Sci. 2017 Mar 1;13(2):404-411. doi: 10.5114/aoms.2016.60822. Epub 2016 Jun 22.
The neutrophil-to-lymphocyte ratio (NLR) is a readily available biomarker associated with recurrence and survival in various diseases. The objective of this study was to investigate the relationship between NLR and pulmonary tuberculosis (PTB) retreatment.
This was a case-control study that included 306 newly diagnosed cases of PTB in the clinical database of the Infectious Hospital of Wuxi from December 2009 to December 2011. Of the 306 patients, a total of 68 cases were followed up with TB retreatment. The remaining 238 PTB patients who completed anti-TB treatment and were cured without retreatment were selected as controls.
According to the ROC curve, the best cut-off value of NLR was 2.53, with a sensitivity of 70.6% and a specificity of 45.4%. The NLR ≥ 2.53 before anti-TB treatment was associated with PTB retreatment (OR = 1.994, 95% CI: 1.116-3.564; adjusted OR (AOR) = 2.409, 95% CI: 1.212-4.788). The retreatment rates with NLR ≥ 2.53 and NLR < 2.53 were 27.1% and 15.5%, respectively, with a significant difference (log-rank test; = 0.010). Additionally, cavitation on chest X-ray (OR = 2.922, 95% CI: 1.654-5.411; AOR = 2.482, 95% CI: 1.230-5.007), history of smoking (OR = 2.202, 95% CI: 1.158-3.493; AOR = 2.321, 95% CI: 1.135-4.745) and age ≥ 60 (OR = 3.828, 95% CI: 1.626-9.015; AOR = 2.931, 95% CI: 1.122-7.653) were also associated with PTB retreatment.
NLR ≥ 2.53 is predictive of PTB retreatment. Otherwise, initial cavitation on chest X-ray, history of smoking, and age of ≥ 60 are also risk factors for PTB retreatment.
中性粒细胞与淋巴细胞比值(NLR)是一种易于获取的生物标志物,与多种疾病的复发和生存相关。本研究的目的是探讨NLR与肺结核(PTB)再治疗之间的关系。
这是一项病例对照研究,纳入了2009年12月至2011年12月无锡市传染病医院临床数据库中306例新诊断的PTB病例。在这306例患者中,共有68例接受了结核病再治疗随访。其余238例完成抗结核治疗且治愈未再治疗的PTB患者被选为对照组。
根据ROC曲线,NLR的最佳截断值为2.53,敏感性为70.6%,特异性为45.4%。抗结核治疗前NLR≥2.53与PTB再治疗相关(OR = 1.994,95%CI:1.116 - 3.564;调整后OR(AOR)= 2.409,95%CI:1.212 - 4.788)。NLR≥2.53组和NLR < 2.53组的再治疗率分别为27.1%和15.5%,差异有统计学意义(对数秩检验;P = 0.010)。此外,胸部X线有空洞(OR = 2.922,95%CI:1.654 - 5.411;AOR = 2.482,95%CI:1.230 - 5.007)、吸烟史(OR = 2.202,95%CI:1.158 - 3.493;AOR = 2.321,95%CI:1.135 - 4.745)和年龄≥60岁(OR = 3.828,95%CI:1.626 - 9.015;AOR = 2.931,95%CI:1.122 - 7.653)也与PTB再治疗相关。
NLR≥2.53可预测PTB再治疗。此外,胸部X线初始有空洞、吸烟史和年龄≥60岁也是PTB再治疗的危险因素。